LABMT

Latin American Bone Marrow Transplantation Group - Helping HSCT growth in the Region - Sharing information - Strengthening ties!

[LABMT @LABMT2]

Do not miss our upcoming webinar on the #EBMT26 highlights later today! 4:00 PM Mexico city time.

Register here:
https://t.co/FH34sOhXrI @TheEBMT #BMTsm

[LABMT @LABMT2]

Join @LABMT2 activities at #EBMT26 on March 23!
See you 🔜 @TheEBMT #BMTsm #CARTcells

[LABMT @LABMT2]

Don't forget to meet us tonight at 8:00 PM! @LABMT2 #Tandem26 @ASTCT

[LABMT @LABMT2]

Let's meet at #Tandem26 come and join us!
@ASTCT #BMTsm #CARTcells

[LABMT @LABMT2]

🇲🇽 Gomez-De-Leon 469

📘 Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia: The Mexican Experience

A national multicenter snapshot of outcomes, challenges, and collaboration in ALL transplantation. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇧🇷 Brazil Schmidt-Filho 784

🦠 Real-World Effectiveness of Letermovir Prophylaxis after Allogeneic HCT in a Middle-Income Country

Real-world data show reduced CMV reactivation and no resistant infections with letermovir prophylaxis. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇲🇽 Ugarte-Pelaez

🏥 Outpatient Allogeneic Hematopoietic Stem Cell Transplantation: Feasibility, Hospitalization Predictors, and Early Mortality

Over 40% fully outpatient HSCT—feasible, safe, and cost-saving. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇧🇷 Gibran-Nunes 528

💊 Loncastuximab Tesirine in Heavily Pretreated DLBCL, Including the Post–CAR-T Setting: A Meta-Analysis

Systematic review shows meaningful activity with manageable toxicity in advanced DLBCL. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇲🇽 Frausto 405

🌎 Breaking Geographic Barriers in a Mexican Ambulatory Transplant Program

Early outcomes show equitable access and comparable survival for national and international patients. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇲🇽 González-Lozano 175

🚀 Safety and Feasibility of Outpatient Myeloablative TMLI-Based Allogeneic Transplantation in High-Risk ALL

Phase I/II trial supporting outpatient delivery with encouraging survival and safety. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇲🇽 Morcos-Sandino 252

👁️ Topical Cyclosporine vs Tacrolimus for Ocular GVHD Prophylaxis after Allogeneic HSCT

Phase I–II trial supporting safe and feasible ocular GVHD prevention strategies. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇧🇷 Arcuri 246

🧪 Joint Use of Rabbit ATG and Posttransplant Cyclophosphamide for HLA-Matched PBSC Transplantation: The Jurassic Phase I/II Trial

Early results support a calcineurin inhibitor–free GVHD prophylaxis strategy. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇲🇽 Sotomayor 378

🛡️ Post-Transplant Cyclophosphamide for GVHD Prophylaxis in HLA-Matched Related Donor HSCT

Real-world outcomes from a Latin American center supporting PTCy in MRD transplants. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇧🇷 | Barroso Duarte 406

⚖️ Comparative Outcomes of Allogeneic HCT in MDS/MPN versus Other Myelodysplastic Syndromes

Registry data confirm inferior survival in MDS/MPN, underscoring the need for tailored strategies. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇲🇽 Burgos-Canales 475

📊 Non-Relapse Mortality in Acute Leukemia: Haploidentical vs Matched Related Donor

Unicentric Mexican experience showing comparable NRM across donor platforms. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇲🇽 Montemayor-Mora 474

🔄 Comparative Outcomes between Haploidentical and HLA-Identical Related HSCT in Northeastern Mexico

Real-world evidence supporting haploidentical transplant as an effective alternative in LMICs. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇲🇽 Ugarte-Pelaez 489

🔗 Short-Duration Blinatumomab for Residual Disease Eradication as a Bridge to Transplant in B-ALL

Innovative, resource-adapted strategy showing high MRD clearance before HCT. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇧🇷 | Simioni 496

📈 Improving Hematopoietic Cell Transplantation Follow-up Data: Completeness Index Assessment of Brazilian Registry Centers

How systematic monitoring and feedback improved national transplant registry data quality. #Tandem26 #BMTsm

[LABMT @LABMT2]

🇲🇽 Armillas-Canseco

🏥 Early Hospital Readmission after Allogeneic Hematopoietic Cell Transplantation

Haploidentical donors and bacterial infections identified as key drivers of early readmission risk.
#Tandem26 #BMTsm

[LABMT @LABMT2]

International | Fingrut

🌍 Inclusive Practices for Safe and Equitable Donor Assessment

Global consensus recommendations to advance donor safety, equity, and inclusion across registries and centers.
#Tandem26 #BMTsm

[LABMT @LABMT2]

Let's meet at #Tandem26 come and join us!
@ASTCT #BMTsm #CARTcells